Epithelial-mesenchymal transition increases during the progression of in situ to invasive basal-like breast cancer

Human Pathology

Volumn 44, Issue 11, 2013, Pages 2581-2589

  Choi, Yoomi ^a   Lee, Hee Jin ^b   Jang, Min Hye ^a   Gwak, Jae Moon ^a   Lee, Kyu Sang ^a   Kim, Eun Joo ^b   Kim, Hyun Jeong ^b   Lee, Hee Eun ^a   Park, So Yeon ^a,b  

^a Seoul National University College of Medicine   (South Korea)

^b Seoul National University Bundang Hospital   (South Korea)

Author keywords

Basal like; Breast cancer; Cancer stem cells; Epithelial mesenchymal transition; Progression

Indexed keywords

ALDH1 PROTEIN; BETA CATENIN; CD146 ANTIGEN; CD24 ANTIGEN; CELL MARKER; HERMES ANTIGEN; NERVE CELL ADHESION MOLECULE; OSTEONECTIN; PROTEIN; SMOOTH MUSCLE ACTIN; UNCLASSIFIED DRUG; UVOMORULIN; VIMENTIN;

ARTICLE; BASAL LIKE BREAST CANCER; CANCER GROWTH; CANCER STEM CELL; CONTROLLED STUDY; DISEASE ASSOCIATION; EPITHELIAL MESENCHYMAL TRANSITION; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; INTRADUCTAL CARCINOMA; INVASIVE CARCINOMA; MAJOR CLINICAL STUDY; PHENOTYPE; PROTEIN DEPLETION; PROTEIN EXPRESSION;

BASAL-LIKE; BREAST CANCER; CANCER STEM CELLS; EPITHELIAL-MESENCHYMAL TRANSITION; PROGRESSION;

ANTIGENS, CD146; BETA CATENIN; BREAST NEOPLASMS; CADHERINS; CARCINOMA, DUCTAL, BREAST; CARCINOMA, INTRADUCTAL, NONINFILTRATING; DISEASE PROGRESSION; EPITHELIAL-MESENCHYMAL TRANSITION; FEMALE; HUMANS; NEOPLASTIC STEM CELLS; PHENOTYPE; TISSUE ARRAY ANALYSIS; TUMOR MARKERS, BIOLOGICAL;

EID: 84885632147     PISSN: 00468177     EISSN: 15328392     Source Type: Journal    
DOI: 10.1016/j.humpath.2013.07.003     Document Type: Article

References (33)

1. D.S. Micalizzi, S.M. Farabaugh, and H.L. Ford Epithelial-mesenchymal transition in cancer: parallels between normal development and tumor progression J Mammary Gland Biol Neoplasia 15 2010 117 134
2. B.G. Hollier, K. Evans, and S.A. Mani The epithelial-to-mesenchymal transition and cancer stem cells: a coalition against cancer therapies J Mammary Gland Biol Neoplasia 14 2009 29 43
3. J.P. Thiery, H. Acloque, R.Y. Huang, and M.A. Nieto Epithelial- mesenchymal transitions in development and disease Cell 139 2009 871 890
4. R. Kalluri, and R.A. Weinberg The basics of epithelial-mesenchymal transition J Clin Invest 119 2009 1420 1428
5. S.A. Mani, W. Guo, and M.J. Liao The epithelial-mesenchymal transition generates cells with properties of stem cells Cell 133 2008 704 715
6. C.M. Perou, T. Sorlie, and M.B. Eisen Molecular portraits of human breast tumours Nature 406 2000 747 752
7. T. Sorlie, C.M. Perou, and R. Tibshirani Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications Proc Natl Acad Sci U S A 98 2001 10869 10874
8. T. Blick, E. Widodo, and H. Hugo Epithelial mesenchymal transition traits in human breast cancer cell lines Clin Exp Metastasis 25 2008 629 642
9. E. Charafe-Jauffret, C. Ginestier, and F. Monville Gene expression profiling of breast cell lines identifies potential new basal markers Oncogene 25 2006 2273 2284
10. D. Sarrio, S.M. Rodriguez-Pinilla, D. Hardisson, A. Cano, G. Moreno-Bueno, and J. Palacios Epithelial-mesenchymal transition in breast cancer relates to the basal-like phenotype Cancer Res 68 2008 989 997
11. H. Jeong, Y.J. Ryu, J. An, Y. Lee, and A. Kim Epithelial-mesenchymal transition in breast cancer correlates with high histological grade and triple-negative phenotype Histopathology 60 2012 E87 E95
12. - breast cancer cells exhibit enhanced invasive properties: an early step necessary for metastasis Breast Cancer Res 8 2006 R59
13. S.Y. Park, H.E. Lee, H. Li, M. Shipitsin, R. Gelman, and K. Polyak Heterogeneity for stem cell-related markers according to tumor subtype and histologic stage in breast cancer Clin Cancer Res 16 2010 876 887
14. M. Hu, J. Yao, and D.K. Carroll Regulation of in situ to invasive breast carcinoma transition Cancer Cell 13 2008 394 406
15. A.E. Place, S. Jin Huh, and K. Polyak The microenvironment in breast cancer progression: biology and implications for treatment Breast Cancer Res 13 2011 227
16. M.H. Jang, E.J. Kim, and Y. Choi FGFR1 is amplified during the progression of in situ to invasive breast carcinoma Breast Cancer Res 14 2012 R115
17. M.A. Lopez-Garcia, F.C. Geyer, M. Lacroix-Triki, C. Marchio, and J.S. Reis-Filho Breast cancer precursors revisited: molecular features and progression pathways Histopathology 57 2010 171 192
18. E.S. Knudsen, A. Ertel, E. Davicioni, J. Kline, G.F. Schwartz, and A.K. Witkiewicz Progression of ductal carcinoma in situ to invasive breast cancer is associated with gene expression programs of EMT and myoepithelia Breast Cancer Res Treat 133 2012 1009 1024
19. B.B. Bryan, S.J. Schnitt, and L.C. Collins Ductal carcinoma in situ with basal-like phenotype: a possible precursor to invasive basal-like breast cancer Mod Pathol 19 2006 617 621
20. C.A. Livasy, C.M. Perou, and G. Karaca Identification of a basal-like subtype of breast ductal carcinoma in situ Hum Pathol 38 2007 197 204
21. A.F. Logullo, S. Nonogaki, F.S. Pasini, C.A. Osorio, F.A. Soares, and M.M. Brentani Concomitant expression of epithelial-mesenchymal transition biomarkers in breast ductal carcinoma: association with progression Oncol Rep 23 2010 313 320
22. - phenotype is enriched in basal-like breast tumors Breast Cancer Res 10 2008 R53
23. J.S. Reis-Filho, F. Milanezi, and D. Steele Metaplastic breast carcinomas are basal-like tumours Histopathology 49 2006 10 21
24. B. Weigelt, B. Kreike, and J.S. Reis-Filho Metaplastic breast carcinomas are basal-like breast cancers: a genomic profiling analysis Breast Cancer Res Treat 117 2009 273 280
25. B.T. Hennessy, A.M. Gonzalez-Angulo, and K. Stemke-Hale Characterization of a naturally occurring breast cancer subset enriched in epithelial-to- mesenchymal transition and stem cell characteristics Cancer Res 69 2009 4116 4124
26. A. Prat, J.S. Parker, and O. Karginova Phenotypic and molecular characterization of the claudin-low intrinsic subtype of breast cancer Breast Cancer Res 12 2010 R68
27. H. Oka, H. Shiozaki, and K. Kobayashi Expression of E-cadherin cell adhesion molecules in human breast cancer tissues and its relationship to metastasis Cancer Res 53 1993 1696 1701
28. S.M. Siitonen, J.T. Kononen, H.J. Helin, I.S. Rantala, K.A. Holli, and J.J. Isola Reduced E-cadherin expression is associated with invasiveness and unfavorable prognosis in breast cancer Am J Clin Pathol 105 1996 394 402
29. R. Heimann, F. Lan, R. McBride, and S. Hellman Separating favorable from unfavorable prognostic markers in breast cancer: the role of E-cadherin Cancer Res 60 2000 298 304
30. T.T. Onder, P.B. Gupta, S.A. Mani, J. Yang, E.S. Lander, and R.A. Weinberg Loss of E-cadherin promotes metastasis via multiple downstream transcriptional pathways Cancer Res 68 2008 3645 3654
31. M. Guarino, B. Rubino, and G. Ballabio The role of epithelial-mesenchymal transition in cancer pathology Pathology 39 2007 305 318
32. J.M. Lehmann, G. Riethmuller, and J.P. Johnson MUC18, a marker of tumor progression in human melanoma, shows sequence similarity to the neural cell adhesion molecules of the immunoglobulin superfamily Proc Natl Acad Sci U S A 86 1989 9891 9895
33. Q. Zeng, W. Li, and D. Lu CD146, an epithelial-mesenchymal transition inducer, is associated with triple-negative breast cancer Proc Natl Acad Sci U S A 109 2012 1127 1132